A sensitive, aqueous-based spectrofluorimetric approach for the determination of favipiravir in presence of its acid-induced degradation product. [PDF]
El-Fattah MHA +3 more
europepmc +1 more source
Emerging antiviral resistant strains of influenza A and the potential therapeutic targets within the viral ribonucleoprotein (vRNP) complex [PDF]
core +1 more source
Sustainable dual-drug analysis: a synchronous spectrofluorimetric approach with integrated greenness and whiteness metrics for favipiravir and levofloxacin. [PDF]
Batakoushy HA +4 more
europepmc +1 more source
Favipiravir as a potent inhibitor of Newcastle disease virus: <i>in ovo</i> efficacy, dose-dependent toxicity, and molecular insights into RNA polymerase inhibition. [PDF]
Soomro NA +4 more
europepmc +1 more source
Trial of ZMapp for Ebola Virus Infection. [PDF]
Fletcher, Tom, Jacob, Shevin T
core +3 more sources
Development of a HiBiT-tagged reporter Akabane virus and its application in antiviral drug screening. [PDF]
Zhang T +8 more
europepmc +1 more source
On topological co-index polynomials for predictive modeling of the physicochemical properties of antiviral drugs. [PDF]
Meharban S +6 more
europepmc +1 more source
Repurposing Metal-Based Therapeutics for Human Metapneumovirus (HMPV): An Integrative Computational Approach. [PDF]
Dubey A +4 more
europepmc +1 more source
Anti-influenza drugs targeting trimeric RNA polymerase complex: From development to clinics. [PDF]
Li Y +6 more
europepmc +1 more source

